Skip to main content
Clinical Trials/NCT04780607
NCT04780607UnknownNot Applicable

Multicenter Results of Mitral Valve Surgery in Patients With Rheumatic Heart Disease

Beijing Anzhen Hospital1 site in 1 country4,000 target enrollmentStarted: January 1, 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
4,000
Locations
1
Primary Endpoint
all-cause mortality

Study Overview

Brief Summary

rheumatic heart disease remains the majority valvular disease in low and middle income countries, which mostly affected mitral valve, surgical treatment is the most effective strategy to improve the outcomes of middle or late-stage RHD patient, however, whether mitral valve repair surgery is superior to replacement or other evolving interventional device remains controversial, this study aims to investigate the results of repair surgery compared with replacement or other treatment strategy from international multicenters.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 1、rheumatic heart disease 2、mitral valve disease 3、combined with other heart valve disease(aortic valve, tricuspid valve, pulmonary valve) 4、patients underwent initial mitral valve surgery or intervention

Exclusion Criteria

  • 1、congenital heart disease degenerative heart valve disease 2、isolated aortic valve or tricuspid valve, pulmonary valve disease( doesn't affect mitral valve ) 3、patients received more than 1 time mitral valve operation

Outcomes

Primary Outcomes

all-cause mortality

Time Frame: 2011-2024

death from any cause

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Beijing Anzhen Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xu Meng

NO.9 department of Cardiac surgery center

Beijing Anzhen Hospital

Study Sites (1)

Loading locations...

Similar Trials